HDL Therapeutics Competitors and Similar CompaniesClear all

HDL Therapeutics's competitors and similar companies include ReShape Lifesciences, ElectroCore, Decibel Therapeutics and FIRE1.

	HDL Therapeutics HDL Therapeutics is a company that develops medical devices for the treatment of coronary atherosclerosis.	ReShape Lifesciences ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.	ElectroCore ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.	Decibel Therapeutics Decibel Therapeutics is a biotechnology company that discovers and develops transformative treatments to restore and improve hearing and balance.	FIRE1 FIRE1 focuses on developing novel remote monitoring devices.
Founding Date	Founding Date 2009	Founding Date 2002	Founding Date 2005	Founding Date 2015	Founding Date N/A
Type	Type Private	Type Public	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech medical devices therapy	Tags Healthcare biotech medical devices therapy	Tags Healthcare biotech medical devices therapy	Tags Healthcare biotech medical devices therapy	Tags Healthcare biotech medical devices therapy
Locations	Locations Vero Beach, US HQ	Locations San Clemente, US HQ San Clemente, US	Locations Rockaway, US HQ Parksville, CA Geretsried, DE Hamburg, DE Yeadon, GB Bernards, US	Locations Boston, US HQ	Locations Dublin, IE HQ Dublin, IE
Employees	Employees 7	Employees 4348% decrease	Employees 5144% decrease	Employees 6810% increase	Employees 838% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 3 m	Valuation ($) 71.2 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $11.3m (FY, 2020)	Revenue (est.) $32m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $5m (FY, 2020)	Cost of goods $4.2m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $6.3m (FY, 2020)	Gross profit $27.8m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ($21.6m) (FY, 2020)	Net income ($14m) (FY, 2025)	Net income ($63m) (FY, 2022)	Net income N/A
Funding
Latest funding round	Latest funding round $ 3m (over 6 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 7.5m (about 10 years ago)
Total funding raised	Total funding raised $ 7.4m	Total funding raised N/A	Total funding raised $ 127m	Total funding raised $ 189m	Total funding raised $ 7.5m

For sources of this data, please see the company profile

View Company Profiles

ReShape Lifesciences

San Clemente, US

Employees

43↓ 48% decrease

ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.

View company

ElectroCore

Rockaway, US

Employees

51↓ 44% decrease

ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.

View company

Decibel Therapeutics

Boston, US

Decibel Therapeutics is a biotechnology company that discovers and develops transformative treatments to restore and improve hearing and balance.

View company

FIRE1